205 related articles for article (PubMed ID: 19775608)
1. The multidisciplinarity of stage III non-small cell lung cancer.
Vansteenkiste J; Dooms C; De Leyn P
Eur J Cancer; 2009 Sep; 45 Suppl 1():92-105. PubMed ID: 19775608
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
3. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a closer look at redo mediastinoscopy.
Granone P; Van Schil P; Cesario A
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):275-6; author reply 276-7. PubMed ID: 17198837
[No Abstract] [Full Text] [Related]
4. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.
De Leyn P; Lardinois D; Van Schil PE; Rami-Porta R; Passlick B; Zielinski M; Waller DA; Lerut T; Weder W
Eur J Cardiothorac Surg; 2007 Jul; 32(1):1-8. PubMed ID: 17448671
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
6. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of remediastinoscopy: influence of adhesions, multilevel N2 involvement, or surgical technique?
Van Schil P; Stamatis G
J Clin Oncol; 2006 Nov; 24(33):5338; author reply 5339-40. PubMed ID: 17114674
[No Abstract] [Full Text] [Related]
8. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
Harewood GC; Wiersema MJ; Edell ES; Liebow M
Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
[TBL] [Abstract][Full Text] [Related]
10. [Strategy for staging non-small cell bronchial carcinoma (NSCLC) with special reference to imaging procedures].
Gückel C; Stulz P; Bolliger CT
Aktuelle Radiol; 1995 Mar; 5(2):79-86. PubMed ID: 7756366
[TBL] [Abstract][Full Text] [Related]
11. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
12. Staging and diagnosis of non-small cell lung cancer: invasive modalities.
Yasufuku K; Fujisawa T
Respirology; 2007 Mar; 12(2):173-83. PubMed ID: 17298448
[TBL] [Abstract][Full Text] [Related]
13. Invited commentary.
Yang SC
Ann Thorac Surg; 2009 Sep; 88(3):928-9. PubMed ID: 19699922
[No Abstract] [Full Text] [Related]
14. Mediastinal staging (take home messages).
Passlick B
Lung Cancer; 2004 Aug; 45 Suppl 2():S85-7. PubMed ID: 15552787
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer staging.
Sihoe AD; Yim AP
J Surg Res; 2004 Mar; 117(1):92-106. PubMed ID: 15013719
[TBL] [Abstract][Full Text] [Related]
16. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal staging of lung cancer. Is mediastinoscopy still essential?
Kristensen S; Aaby C; Nielsen SM
Dan Med Bull; 1995 Apr; 42(2):192-4. PubMed ID: 7664577
[TBL] [Abstract][Full Text] [Related]
18. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-myoepithelial carcinoma of the lung.
Sainathan S; Pugalenthi A; Danovich S; Arif F; Andaz S
Am Surg; 2012 May; 78(5):E290-1. PubMed ID: 22691334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
